Ayala

3 stories about Ayala
נאסדק

Ayala Pharmaceuticals Headed for Nasdaq IPO

07.01.20|Golan Hazani
The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation
ילד חולה ילדים חולים

Ayala Pharmaceuticals Raises $30 Million

29.05.19|Adi Pick
The Israel-based company intends to use the new round of funding to advance the clinical development of its anti-cancer product
אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies